Abstract: The present invention relates to a periodic acid oxidation which converts the penultimate intermediate bearing a primary alcohol to the target endothelin antagonist compound of Formula I having a carboxylic acid.
Type:
Grant
Filed:
April 1, 1999
Date of Patent:
January 9, 2001
Assignee:
Merck & Co., Inc.
Inventors:
Zhiguo Song, Mangzu Zhao, David M. Tschaen